Pharmaceutical

Samsung Biologics and LigaChem extend ADC services deal

Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services.

Jan 10, 2025 - 06:00
Samsung Biologics and LigaChem extend ADC services deal
Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services.
Read the original article

Tags:

Previous Article

Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe

Next Article

UK-based Verdiva launches with $410m and an oral GLP-1RA candidate  

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Forbion raises $1.47bn for two life sciences-focused funds

Forbion raises $1.47bn for two life sciences-focused funds

Apr 20, 2023

An effort to diversify genetic research finds new variant for Parkinson’s disease in African populations

An effort to diversify genetic research finds new varia...

Aug 25, 2023

STAT+: DOJ, FTC primed for more aggressive scrutiny of health care mergers

STAT+: DOJ, FTC primed for more aggressive scrutiny of ...

Jul 20, 2023